Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) stock analysis

In our weekly check, Jiangsu Hengrui Medicine Co., Ltd. is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 22 pass, warnings: 2, red flags: 1.

About Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in China, listed on SHH as 600276.SS.

What our checks show for 600276.SS

Red flags

• The stock has fallen as much as 71% from a peak. Would you have held through that?

Warning signs

• The price is 35.9 times earnings (P/E): the market already pays for a lot of future growth.
• The stock is still below its previous peak.

Strengths

• Debt is low: 0.01x equity.
• Operating profit covers interest 1503 times over.
• The net margin rose by 9.6 points over 5 years, to 27%.
• Analysts expect earnings per share to grow about 13.9% a year over the next years.
• Analysts expect the net margin to improve by 4 points from today's 27%.
• Revenue grew 15.6% a year over the last 3 years.

Similar companies

3692.HK · IPCALAB.NS · 6446.TW · GLENMARK.NS · LUPIN.NS · AUROPHARMA.NS

Questions

What grade does Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) have?

In our weekly check, Jiangsu Hengrui Medicine Co., Ltd. is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 22 pass, warnings: 2, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 600276.SS stock?

This week's biggest flags for Jiangsu Hengrui Medicine Co., Ltd.: Deep past fall, High P/E, Slow recovery after falls. In total 3 of 25 checks show a warning or a red flag.

What does Jiangsu Hengrui Medicine Co., Ltd. do?

Jiangsu Hengrui Medicine Co., Ltd. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in China, listed on SHH as 600276.SS.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis